Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130.

Narazaki M, Witthuhn BA, Yoshida K, Silvennoinen O, Yasukawa K, Ihle JN, Kishimoto T, Taga T.

Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2285-9.

2.

Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association.

Matsuda T, Fukada T, Takahashi-Tezuka M, Okuyama Y, Fujitani Y, Hanazono Y, Hirai H, Hirano T.

J Biol Chem. 1995 May 12;270(19):11037-9.

5.

Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines.

Matsuda T, Takahashi-Tezuka M, Fukada T, Okuyama Y, Fujitani Y, Tsukada S, Mano H, Hirai H, Witte ON, Hirano T.

Blood. 1995 Feb 1;85(3):627-33.

8.

IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase.

Murakami M, Hibi M, Nakagawa N, Nakagawa T, Yasukawa K, Yamanishi K, Taga T, Kishimoto T.

Science. 1993 Jun 18;260(5115):1808-10.

PMID:
8511589
9.

Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.

Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S, et al.

Science. 1994 Jan 7;263(5143):92-5.

PMID:
8272873
10.

Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.

Kurth I, Horsten U, Pflanz S, Dahmen H, Küster A, Grötzinger J, Heinrich PC, Müller-Newen G.

J Immunol. 1999 Feb 1;162(3):1480-7.

11.
12.

Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions.

Dahmen H, Horsten U, Küster A, Jacques Y, Minvielle S, Kerr IM, Ciliberto G, Paonessa G, Heinrich PC, Müller-Newen G.

Biochem J. 1998 May 1;331 ( Pt 3):695-702.

13.

Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms.

Blanchard F, Wang Y, Kinzie E, Duplomb L, Godard A, Baumann H.

J Biol Chem. 2001 Dec 14;276(50):47038-45. Epub 2001 Oct 15.

14.

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L.

Biochem J. 1998 Sep 1;334 ( Pt 2):297-314. Review.

15.
16.

Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.

Anhuf D, Weissenbach M, Schmitz J, Sobota R, Hermanns HM, Radtke S, Linnemann S, Behrmann I, Heinrich PC, Schaper F.

J Immunol. 2000 Sep 1;165(5):2535-43.

17.

Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.

Giordano V, De Falco G, Chiari R, Quinto I, Pelicci PG, Bartholomew L, Delmastro P, Gadina M, Scala G.

J Immunol. 1997 May 1;158(9):4097-103.

PMID:
9126968
19.

Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes.

Oh H, Fujio Y, Kunisada K, Hirota H, Matsui H, Kishimoto T, Yamauchi-Takihara K.

J Biol Chem. 1998 Apr 17;273(16):9703-10.

Supplemental Content

Support Center